5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) Pipeline Report 2016 - Review of 9 Companies & Drug Profiles - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6), complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) Overview
  3. Therapeutics Development
  4. Pipeline Products for 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) - Overview
  5. Pipeline Products for 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) - Comparative Analysis
  6. 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) - Therapeutics under Development by Companies
  7. 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) - Therapeutics under Investigation by Universities/Institutes
  8. 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) - Products under Development by Companies
  13. 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) - Products under Investigation by Universities/Institutes
  14. 5-Hydroxytryptamine Receptor 6 (5-HT-6 or Serotonin Receptor 6 or HTR6) - Companies Involved in Therapeutics Development
  • Adamed Sp. z o.o.
  • Avineuro Pharmaceuticals, Inc.
  • Axovant Sciences Ltd.
  • Biotie Therapies Corp.
  • Galenea Corp.
  • H. Lundbeck A/S
  • Reviva Pharmaceuticals Inc.
  • Suven Life Sciences Ltd.
  • Teva Pharmaceutical Industries Ltd.

For more information visit http://www.researchandmarkets.com/research/9pzqwm/5hydroxytryptamin

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716